Rep. Kevin Hern (R-OK) Sells UnitedHealth (UNH) Stock
Oklahoma Congressman Kevin Hern sold shares of UnitedHealth Group, valued between $15,001 and $50,000.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Kevin Hern (R-OK) sold between $15,001 and $50,000 of UnitedHealth Group Incorporated ($UNH) stock on September 23, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed October 13, 2026.
Since the trade, $UNH is down 1.1% after 1 week and up 8.1% to date (from the $371.29 close on Sep 23, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Kevin Hern (R-OK)
- Status:
- Member — House
- State/District:
- OK-1
- Party:
- Republican
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Oct 13, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| UnitedHealth Group Incorporated ($UNH) | Sell | Sep 23, 2026 | $15,001 - $50,000 |
Summary of the filed report, not the original document. View the original: STOCK Act disclosure (House Clerk)
UNH
UnitedHealth Group Incorporated
Key Points
- On September 23, 2026, Congressman Kevin Hern sold shares of UnitedHealth Group valued between $15,001 and $50,000.
- Recently, shares of UnitedHealth Group have traded around $402.70, which is below the average price target of $477.04 set by analysts.
- The company's next earnings report is set for January 26, 2027, and it has a P/E ratio of 26.15.
Get $UNH trade alerts by text
We text you when insiders, Congress or big funds trade $UNH. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated UnitedHealth Group Incorporated alert may contain errors. Disclosures
Oklahoma Congressman Kevin Hern sold shares of UnitedHealth Group Incorporated (NYSE: UNH) on September 23, 2026. The transaction was valued between $15,001 and $50,000, according to a report filed under the STOCK Act on October 13, 2026.
Kevin Hern vs. the S&P 500
Hypothetical returns from Kevin Hern's disclosed trades, not real profit or advice. How we model this.
Inside Kevin Hern's Trade
Kevin Hern, a Republican member of the House, reported this sale which adds to his previous transactions. This marks his second reported sale since September 2, when he sold shares of TJX Companies valued in the same range.
Other Institutional Activity in UnitedHealth Group
Several major funds hold significant stakes in UnitedHealth Group. Blackrock Inc. increased its holdings by 3,394,259 shares, resulting in a total of 76,863,061 shares worth about $30.9 billion. Vanguard Capital Management LLC added 441,525 shares, bringing its total to 59,311,525 shares valued at approximately $23.8 billion. State Street Corporation grew its position by 299,205 shares, ending with 45,633,267 shares worth around $18.3 billion. Additionally, Capital World Investors increased its stake by 2,103,297 shares, totaling 29,887,932 shares valued at about $12.0 billion.
UnitedHealth Group Incorporated Stock Up 1.5%
As of October 16, 2026, UnitedHealth Group's shares are trading around $402.70, which is above its 50-day moving average of $387.35 and its 200-day moving average of $358.75. However, this price is about 12.8% below its 52-week high of $461.62 and 15.6% below the average price target set by analysts.
Recent Earnings
In its most recent earnings report, UnitedHealth Group reported a trailing twelve-month revenue of approximately $450.1 billion and an EPS of $15.55. The company has a net margin of 3.5% and a return on equity of 15.8%. The next earnings report is scheduled for January 26, 2027.
Analysts Set New Price Targets
On October 14, 2026, multiple analysts maintained their ratings on UnitedHealth Group. TD Cowen kept its rating at Hold with a target price of $402.00, down from $430.00. Piper Sandler maintained an Overweight rating and raised its target to $504.00 from $502.00. Barclays also kept its Overweight rating with a target of $440.00, slightly down from $441.00.
About UnitedHealth Group
UnitedHealth Group Incorporated is a healthcare company that operates through various segments, including Optum Health and UnitedHealthcare. The company provides a range of health services and plans to individuals and organizations in the U.S. and internationally. This recent stock trade comes amid ongoing activities and interest from institutional investors in the healthcare sector.
Bottom Line
Investors will want to watch for UnitedHealth Group's upcoming earnings report on January 26, 2027, and further disclosures from Congressman Hern regarding his stock trades. The company continues to attract attention from analysts and institutional investors alike.
Related Filing Alerts
Source: Kevin Hern's STOCK Act disclosure on $UNH (Sep 23, 2026). Read the original filing: STOCK Act disclosure (House Clerk). Written by software, not financial advice. How we make alerts